Abstract Circuit

The Nasdaq Junior Biotechnology Index

Available to investors through the Defiance Nasdaq Junior Biotechnology ETF (IBBJ), this strategy offers a "pure-play" approach to investing in some of today's most important healthcare R&D companies. 

Nasdaq Global Indexes
Author
Nasdaq Index Insights Team
Published

In what may be the most consequential backdrop imaginable, the Nasdaq Junior Biotechnology Index (NBIJR) launched on April 30, 2020 in the midst of the coronavirus pandemic. Available to investors through the Defiance Nasdaq Junior Biotechnology ETF (IBBJ), this strategy offers a "pure-play" approach to investing in some of today's most important healthcare R&D companies. 

The Nasdaq Junior Biotechnology Index Performance

Click here to read the full report.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NBIJR

Other Topics

BioTech
Nasdaq Global Indexes

Nasdaq Index Insights Team

Nasdaq

Nasdaq calculates more than 40,000 diverse indexes, providing coverage across asset classes, countries and sectors.

Read Nasdaq Index Insights Team's Bio